IOVA FY 2016 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

IOVAIovance Biotherapeutics, Inc.

$2B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$978,000

Operating Income

-$54M

Net Income

-$53M

EPS (Diluted)

$-0.96

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$34M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$172M

Total Liabilities

$5M

Stockholders' Equity

$167M

Cash & Equivalents

$166M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$978,000	-$999,000	+2.1%
Operating Income	-$54M	-$28M	-92.5%
Net Income	-$53M	-$28M	-91.2%